The Global Healthcare Innovation Alliance Accelerator (GHIAA)
Policy to Impact
GHIAA creates resources, curates information, collaborates with stakeholders and provides consulting support related to policies and agreement provisions that aim to achieve equitable, global access to medical products.
Our Work
MAPGuideⓇ Platform
Agreement Provisions, Analysis, Equitable Access Resources
MAPGuideⓇ Platform
The MAPGuideⓇ platform is a tool for exploring analysis of global health agreements, particularly those that seek to ensure equitable access to medical products.
Resources on the platform include our Provision Database, Equitable Access Toolkit, and Equitable Access Glossary.
Access MAPGuideⓇ Platform
Consulting Services
Expert advice for access plans, provisions and policies
Consulting Services
We have substantial subject matter expertise in negotiating global health agreements, and has worked extensively with organizations seeking to increase access to medical products. We provide practical, pragmatic advice for organizations seeking to navigate the complexities of developing and implementing access plans and agreement provisions.
Find out more
Strategic Insights
For new vaccine manufacturing
initiatives
initiatives
Vaccine Manufacturing
GHIAA has developed and contributed to a number of publications and events on the topic of equitable access to COVID-19 vaccines. In particular, we have focused on the role of agreement terms in supporting increased and accelerated access for underserved populations, both for COVID-19 vaccines and for future vaccine needs.
Read more
MAPGuideⓇ Platform
Agreement Provisions, Analysis, Equitable Access Resources
MAPGuideⓇ Platform
The MAPGuideⓇ platform is a tool for exploring analysis of global health agreements, particularly those that seek to ensure equitable access to medical products.
Resources on the platform include our Provision Database, Equitable Access Toolkit, and Equitable Access Glossary.
Access MAPGuideⓇ Platform
Consulting Services
Expert advice for access plans, provisions and policies
Consulting Services
We have substantial subject matter expertise in negotiating global health agreements, and has worked extensively with organizations seeking to increase access to medical products. We provide practical, pragmatic advice for organizations seeking to navigate the complexities of developing and implementing access plans and agreement provisions.
Find out more
Strategic Insights
For new vaccine manufacturing initiatives
Vaccine Manufacturing
GHIAA has developed and contributed to a number of publications and events on the topic of equitable access to COVID-19 vaccines. In particular, we have focused on the role of agreement terms in supporting increased and accelerated access for underserved populations, both for COVID-19 vaccines and for future vaccine needs.
Read more
MAPGuideⓇ Platform
Agreement Provisions, Analysis, Equitable Access Resources
MAPGuideⓇ Platform
The MAPGuideⓇ platform is a tool for exploring analysis of global health agreements, particularly those that seek to ensure equitable access to medical products.
Resources on the platform include our Provision Database, Equitable Access Toolkit, and Equitable Access Glossary.
Access MAPGuideⓇ Platform
Consulting Services
Expert advice for access plans, provisions and policies
Consulting Services
We have substantial subject matter expertise in negotiating global health agreements, and has worked extensively with organizations seeking to increase access to medical products. We provide practical, pragmatic advice for organizations seeking to navigate the complexities of developing and implementing access plans and agreement provisions.
Find out more
Strategic Insights
For new vaccine manufacturing
initiatives
initiatives
Vaccine Manufacturing
GHIAA has developed and contributed to a number of publications and events on the topic of equitable access to COVID-19 vaccines. In particular, we have focused on the role of agreement terms in supporting increased and accelerated access for underserved populations, both for COVID-19 vaccines and for future vaccine needs.
Read more
Latest News
- August 30, 2024
WHO Pandemic Agreement: Recommendations for INB 11
Ahead of INB 11, GHIAA has published its comments and recommendations on the latest proposed text for the WHO Pandemic Agreement. Read the commentary. - July 13, 2024
GHIAA calls for CSO Access to Pandemic Agreement Negotiations
Along with 140 supporters form 40 different countries, GHIAA has signed on to Pandemic Action Network’s Partner Call for Action. The open letter demands the official inclusion of civil society organizations (CSOs) in the INB Pandemic Agreement negotiation process Read the full letter and sign here. - April 10, 2024
Julie to Speak at Conference on Resolving Vaccine Inequality
Julie is an invited speaker at the British Academy Conference on Resolving Vaccine Inequity. Hosted at the SOAS University of London from April 11-12, this year’s conference theme is Resolving Global Vaccine Inequality: Innovation, Capabilities and Governance. Julie will be speaking during the “Vaccine Nationalism, Vaccine Inequity, Production and IPR” session starting at 1:30pm BST on April 11 and will specifically address intellectual property rights, pharma product licensing, and global public health security. Register and learn more. - March 27, 2024
Ongoing Review of the Pandemic Accord
GHIAA has published comprehensive comments and recommendations regarding the most recent negotiating texts for the Pandemic Agreement. Read Our Commentary Here